Hyperbaric Medical Solutions (HMS) is proud to announce it has joined the Mount Sinai Health Partners IPA, becoming the IPA's only participating provider of hyperbaric oxygen therapy (HBOT).
Mount Sinai Health Partners (MSHP) is a network of physicians dedicated to providing high-quality, low-cost, community-based health care. MSHP not only embraces the shift in health care towards population health management and accountability of quality and cost, it is a leader in this transformation. HMS fits perfectly within that model, providing HBOT at a fraction of the cost of traditional hospital-based programs. With HMS joining the IPA, Mount Sinai physicians are engaged to incorporate this safe, non-invasive treatment into their patients’ health care plans.
Established in 2011, HMS is an independent HBOT provider based on Long Island with locations in Manhattan, Woodbury, and Medford, as well as another location opening soon in White Plains. HMS strives to co-manage patients with their referring providers, focusing on providing high-quality HBOT while collaborating with the patient’s other primary and specialty physicians to ensure that every patient receives premier, customized care. Each patient is carefully assessed by our medical team based on their condition(s) to create a specific recovery plan.
HMS uses the healing power of HBOT to treat conditions, such as radiation tissue damage, non-healing wounds, and diabetic lower extremity wounds (diabetic foot ulcer). Although HBOT has not yet been approved by the FDA for treating other conditions such as concussions, strokes, chronic pain, Lyme disease, and Multiple Sclerosis, research and the experience of HMS, as well as the experience of other providers, has shown efficacy using HBOT for these conditions.
Written by Alan Katz, MD, FUHM, FACEP, FAAEM
Dr. Alan Katz, National Medical Director of Hyperbaric Medical Solutions (HMS), is double board certified in Emergency Medicine and Hyperbaric Medicine. He directs clinical operations, as well as education and research initiatives for HMS, particularly in exploring the use of hyperbaric oxygen therapy....Read More